whalepapers
Overview/ Baupost Group Llc/Ma/ Q1 2018

Baupost Group Llc/Ma

Seth Klarman · As of Q1 2018 · filed May 14, 2018

Q1 2018

Holdings

33 positions · Δ vs prior quarter
LNG CHENIERE ENERGY INC
$1.11B
10.7%
20,726,340 Held
SYF SYNCHRONY FINANCIAL
$982.3M
9.5%
29,295,030 Held
TWENTY FIRST CENTY FOX INC
$975.5M
9.4%
26,588,731 +4,300,000 +19.3% Added
VSAT VIASAT INC
$897.6M
8.7%
13,658,137 +500,000 +3.8% Added
ACTEUR ALLERGAN PLC
$799.4M
7.7%
4,750,000 +250,000 +5.6% Added
QRVO QORVO INC
$775.0M
7.5%
11,000,000 Held
TWXUSD TIME WARNER INC
$766.1M
7.4%
8,100,000 Held
PXDEUR PIONEER NATURAL RESOURCES CO
$687.1M
6.6%
4,000,000 +2,000,000 +100.0% Added
AR ANTERO RESOURCES CORP
$527.8M
5.1%
26,587,791 +1,865,604 +7.5% Added
TWENTY FIRST CENTY FOX INC
$415.8M
4.0%
11,433,358 +902,100 +8.6% Added
CAH CARDINAL HEALTH INC
$319.7M
3.1%
5,100,000 Held
COLONY NORTHSTAR INC
$279.2M
2.7%
49,687,370 +1,781,909 +3.7% Added
PBF PBF ENERGY INC-CLASS A
$268.6M
2.6%
7,924,175 −3,000,000 −27.5% Reduced
ATRAGBX ATARA BIOTHERAPEUTICS INC
$243.9M
2.4%
6,254,632 +895,000 +16.7% Added
MCK MCKESSON CORP
$227.6M
2.2%
1,615,700 +255,700 +18.8% Added
TBPH THERAVANCE BIOPHARMA INC
$225.7M
2.2%
9,309,168 Held
VRTVEUR VERITIV CORP
$149.9M
1.4%
3,824,385 +182,900 +5.0% Added
PCG P G & E CORP
$138.4M
1.3%
3,149,972 +3,149,972 New
COR CENCORA INC
$113.6M
1.1%
1,317,216 −117,349 −8.2% Reduced
KERYX BIOPHARMACEUTICALS INC
$105.5M
1.0%
25,791,678 Held
AMC ENTMT HLDGS INC
$70.3M
0.7%
5,000,000 Held
NG NOVAGOLD RESOURCES INC
$58.3M
0.6%
13,467,145 +2,724,310 +25.4% Added
TSLA 2.375 03/15/22 PRN TESLA INC
$52.2M
0.5%
50,000,000 +50,000,000 New
GTY TECHNOLOGY HOLDINGS INC
$45.5M
0.4%
4,400,000 Held
PRTKEUR PARATEK PHARMACEUTICALS INC
$31.1M
0.3%
2,394,498 Held
TBPH 3.25 11/01/23 PRN THERAVANCE BIOPHARMA INC
$30.2M
0.3%
30,000,000 Held
SABAN CAP ACQUISITION CORP
$23.1M
0.2%
2,326,500 Held
SENTINEL ENERGY SVCS INC
$15.9M
0.2%
1,600,000 Held
CHIPMOS TECHNOLOGIES INC
$14.8M
0.1%
933,658 −536,750 −36.5% Reduced
TMQ TRILOGY METALS INC
$13.4M
0.1%
10,600,758 Held
FORWARD PHARMA A/S
$6.2M
0.1%
2,848,003 −1,331,937 −31.9% Reduced
SABAN CAP ACQUISITION CORP
$1.5M
0.0%
1,163,250 Held
OREXIGEN THERAPEUTICS INC
$465K
0.0%
2,226,839 Held

Sold positions

3 closed in Q1 2018 · shares & value as of prior filing
Holding Shares sold Prior value
EXPRESS SCRIPTS HLDG CO
2,306,456 $172.2M
CASCADIAN THERAPEUTICS INC
8,721,079 $32.3M
RUN SUNRUN INC
2,848,082 $16.8M

Holdings reflect long positions disclosed in 13F filings only and exclude short positions, cash, and other non-13F assets. Holdings data sourced from SEC EDGAR. Not investment advice. Full disclaimer.